Treace Medical Concepts (TMCI) Gains from Sales and Divestitures (2022 - 2024)
Historic Gains from Sales and Divestitures for Treace Medical Concepts (TMCI) over the last 3 years, with Q4 2024 value amounting to $327680.0.
- Treace Medical Concepts' Gains from Sales and Divestitures rose 11857.14% to $327680.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $327680.0, marking a year-over-year increase of 11857.14%. This contributed to the annual value of $327680.0 for FY2024, which is 11857.14% up from last year.
- Per Treace Medical Concepts' latest filing, its Gains from Sales and Divestitures stood at $327680.0 for Q4 2024, which was up 11857.14% from $149919.0 recorded in Q4 2023.
- In the past 5 years, Treace Medical Concepts' Gains from Sales and Divestitures ranged from a high of $327680.0 in Q4 2024 and a low of $6223.0 during Q4 2022
- Moreover, its 3-year median value for Gains from Sales and Divestitures was $149919.0 (2023), whereas its average is $161274.0.
- In the last 5 years, Treace Medical Concepts' Gains from Sales and Divestitures surged by 230911.14% in 2023 and then skyrocketed by 11857.14% in 2024.
- Treace Medical Concepts' Gains from Sales and Divestitures (Quarter) stood at $6223.0 in 2022, then skyrocketed by 2309.11% to $149919.0 in 2023, then soared by 118.57% to $327680.0 in 2024.
- Its Gains from Sales and Divestitures stands at $327680.0 for Q4 2024, versus $149919.0 for Q4 2023 and $6223.0 for Q4 2022.